<DOC>
	<DOCNO>NCT01299584</DOCNO>
	<brief_summary>This study post-marketing surveillance monitor safety efficacy remifentanil various surgery identify SAEs , adverse drug reaction , unexpected AEs describe precaution warning identify prognostic factor effect AEs ass effectiveness remifentanil real clinical practice marketing . The subject patient prescribed remifentanil investigator site base prescription information normal clinical practice .</brief_summary>
	<brief_title>ULTIVA Post Marketing Surveillance</brief_title>
	<detailed_description />
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Patients require general anesthesia According precaution warning PI , remifentanil administer following patient Patients allergic reaction ingredient remifentanil fentanyl analogue</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>